International workshop on immune tolerance induction: consensus recommendations.
about
Rituximab for treating inhibitors in people with inherited severe hemophiliaRituximab for treating inhibitors in children with hemophiliaImmunogenicity of protein therapeutics: The key causes, consequences and challengesHuman von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia AAlloantibodies to therapeutic factor VIII in hemophilia A: the role of von Willebrand factor in regulating factor VIII immunogenicityClinical use and the Italian demand for activated prothrombin complex and activated recombinant factor VII concentratesThe current state of adverse event reporting in hemophilia.The evolution of comprehensive haemophilia care in the United States: perspectives from the frontline.First analysis of 10-year trends in national factor concentrates usage in haemophilia: data from CHARMS, the Canadian Hemophilia Assessment and Resource Management System.Global Post-Authorization Safety Surveillance Study: real-world data on prophylaxis and on-demand treatment using FEIBA (an activated prothrombin complex concentrate).Treatment and Prevention of Bleeds in Haemophilia Patients with Inhibitors to Factor VIII/IXCurrent and evolving features in the clinical management of haemophiliaPhysical and psychosocial challenges in adult hemophilia patients with inhibitors.Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practicePrinciples of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in ItalyEffect of B-cell depletion using anti-CD20 therapy on inhibitory antibody formation to human FVIII in hemophilia A mice.Barriers to primary prophylaxis in haemophilic children: the issue of the venous access.Hemophilia care in India: a review and experience from a tertiary care centre in uttar pradesh.A role for von Willebrand factor in immune tolerance induction in patients with haemophilia A and inhibitors?Cost-utility analysis of immune tolerance induction therapy versus on-demand treatment with recombinant factor VII for hemophilia A with high titer inhibitors in IranTreatment of hemophilia: a review of current advances and ongoing issuesChallenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia A and high-titer inhibitors.Issues in pediatric haemophilia careThe use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.Improved treatment feasibility in children with hemophilia using arteriovenous fistulae: the results after seven years of follow-up.Clinical use of factor VIII and factor IX concentratesKey issues in inhibitor management in patients with haemophilia.When should prophylaxis therapy in inhibitor patients be considered?Inherited disorders of blood coagulation.Factor VIII inhibitors: a 50-year perspective.Clinical advances in hemophilia management.Immune tolerance induction in haemophilia: evidence and the way forward.Immune tolerance induction for patients with severe hemophilia A: a critical literature review.The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experience.Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice.Management of bleeding disorders in adults.Inhibitors in childhood hemophilia A: genetic and treatment-related risk factors for development and eradication.More than a decade of international experience with a pdFVIII/VWF concentrate in immune tolerance.The reversal of inhibitors in congenital hemophilia.A review of immune tolerance induction with Haemate P in haemophilia A.
P2860
Q24186623-7A9A485D-85F0-40A2-B97C-39645FC938F0Q24197700-E18929AC-8E7A-4E12-8B1D-390E8F9A33A7Q24633296-584E2228-B0F9-4C46-A1B6-362CF67F8B9DQ26738507-71A21420-6FD1-472B-B242-E2A171B4CAD4Q26866323-15BF2B02-1BF0-4303-ADD2-B27A329E4E27Q27026389-5BD9E053-8F27-400C-BEA4-704C3F0ACD58Q30239952-60EA868F-B39D-4AE8-B143-5787B6A51828Q30249256-67D0DB6F-A77E-4430-BA30-4D4613B7980EQ30832356-8F3C16E1-C5CB-4064-8A6A-3821B400FF29Q31041664-4ADA4093-4C80-4707-A73A-EB3D2A9CC171Q33608230-0426A7A7-B1BB-4A80-A07D-2BEEF5476D22Q33708976-8F51A982-AF81-40C0-B94B-1D2549C2CED1Q33968730-37847756-6385-4A1B-8DA6-387FD3780B8FQ34157402-E920BF2C-2A2D-4B1F-B716-3543B5A1B2A6Q34416394-0D10D019-072A-4E17-9657-8E76BBED4425Q34707338-0C1C0841-A6D1-41BC-B34C-7E79970A04C1Q34910120-E73E3531-76BE-4F07-8B1E-75301BD443DDQ35163225-85621E9E-0754-40A4-B6DD-A5DC14DFD6CFQ35176160-25DE807C-3580-4A41-91D0-25DA52B036DDQ35602600-8F806C7A-9A63-4122-85BC-8CDB964AE4F8Q35683781-48663529-90E1-41F4-B348-911DA8AAD5D1Q36019034-CC9E5289-1799-4532-9A54-2AC0DDFF9CE8Q36835166-17BBFC7B-E3A2-4053-ADC1-A23B1B589A62Q37032857-5C5136FE-573E-439A-A05A-1F812085FEB1Q37175598-86BECDBC-695B-4870-B3E5-1D4304943800Q37370356-1BF3ED1D-887B-4319-8832-0C084BD1B97FQ37602415-BF64678C-16C9-4F68-BA5D-DE1997C852B7Q37854874-E8B3B0DF-F2D3-47D6-94F4-F3BC0E5E6858Q37876411-7C68EDB2-E134-4773-A1D1-859CF48D45D1Q37876956-DB260C94-9626-4600-A739-DD1696FD4C28Q37900933-A3C12CE9-1E67-46EF-A8AC-BB63F71C7A5BQ37903944-8D1031D0-5FA4-4D35-813D-8D6E8F1C6CF8Q37912059-C2C69B74-47A5-4223-A572-06E06308607AQ37924970-C3C217AD-6057-49D0-958E-066BBA1500ADQ37977140-B58EF66D-6FF9-473D-8B18-B49E2F2D1FDDQ38005180-AF7FFF30-6CA9-4E9B-8DE1-96568BA9786EQ38056462-4E2C6433-89D8-4997-BE59-33ABD5272CA7Q38070812-13248C03-9018-4463-9B3D-39167782B9AFQ38077139-E43536F1-5AF5-4D63-9514-A1B6FA7D7366Q38156000-3E01AA23-1A34-475B-B223-5D4C23A0D041
P2860
International workshop on immune tolerance induction: consensus recommendations.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
International workshop on immune tolerance induction: consensus recommendations.
@en
type
label
International workshop on immune tolerance induction: consensus recommendations.
@en
prefLabel
International workshop on immune tolerance induction: consensus recommendations.
@en
P2093
P2860
P1433
P1476
International workshop on immune tolerance induction: consensus recommendations.
@en
P2093
DiMichele DM
Santagostino E
P2860
P356
10.1111/J.1365-2516.2007.01497.X
P478
13 Suppl 1
P577
2007-07-01T00:00:00Z